Los Angeles Capital Management’s BioLife Solutions BLFS Stock Holding History

Los Angeles Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$100K	Sell	3,546 -10,445	-75%	-$244K	﹤0.01%	1345
2026 Q1	$267K	Buy	13,991 +13,780	+6,531%	+$305K	﹤0.01%	1068
2025 Q4	$5.68K	Buy	+211	New	+$5.52K	﹤0.01%	2253
2024 Q4	–	Sell	-19,863	Closed	-$497K	–	1126
2024 Q3	$497K	Sell	19,863 -190	-0.9%	-$4.49K	﹤0.01%	865
2024 Q2	$430K	Buy	+20,053	New	+$389K	﹤0.01%	903
2023 Q3	–	Sell	-32,228	Closed	-$712K	–	1126
2023 Q2	$712K	Sell	32,228 -11,615	-26%	-$245K	﹤0.01%	746
2023 Q1	$954K	Sell	43,843 -628	-1%	-$14.1K	﹤0.01%	688
2022 Q4	$809K	Buy	44,471 +15,401	+53%	+$318K	﹤0.01%	764
2022 Q3	$661K	Buy	29,070 +220	+0.8%	+$4.71K	﹤0.01%	837
2022 Q2	$398K	Sell	28,850 -1,300	-4%	-$19.1K	﹤0.01%	1051
2022 Q1	$685K	Buy	+30,150	New	+$794K	﹤0.01%	911

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Los Angeles Capital Management's BLFS Position: Q2 2026 in Review

Los Angeles Capital Management reduced its BioLife Solutions (BLFS) stake by 75% in Q2 2026, selling an estimated $244K and leaving 3,546 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Los Angeles Capital Management first reported a position in BLFS in Q1 2022 and has held it in 11 quarters since. The position peaked at $954K in Q1 2023. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Los Angeles Capital Management held 3,546 shares of BioLife Solutions worth $100K as of Q2 2026.
Los Angeles Capital Management sold 10,445 BioLife Solutions shares in Q2 2026, an estimated $244K.
BioLife Solutions made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1345 holding.
Los Angeles Capital Management first reported a position in BioLife Solutions in Q1 2022 and has held it in 11 quarters since.
Los Angeles Capital Management's BioLife Solutions position peaked at $954K in Q1 2023.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.